(Total Views: 685)
Posted On: 02/17/2025 7:55:09 PM
Post# of 155519
Dr. Emily Kansigo on Max's profile, is Tanzania:
Currently, Kansigo is working as ADULT CARE AND TREATMENT TB/HIV OFFICER at ICAP. His primary role is to oversee and coordinate the implementation of Adult HIV Care, treatment of TB and HIV services at NYAMAGANA DISTRICT.
Previosly he worked as Clinician at Dodoma Regional Refferal Hospital (DRRH) under the USAID Afya Yangu Northern program, which is implemented by the Elizabeth Glaser Pediatric Foundation (EGPAF) and the Benjamin Mkapa Foundation (BMF).
HIV prevalence in Tanzania
The 2022–2023 Tanzania HIV Impact Survey found that HIV prevalence varies by region, ranging from 1.7% in Kigoma to 12.7% in Njombe.
___
Looks like Leronlimab's destination is the underserved regions that GF & ViiV(GSK) have targeted for decades.
Block, kill the resevoir & cure breastfeeding.
BG --- "a cure is on the way"
Currently, Kansigo is working as ADULT CARE AND TREATMENT TB/HIV OFFICER at ICAP. His primary role is to oversee and coordinate the implementation of Adult HIV Care, treatment of TB and HIV services at NYAMAGANA DISTRICT.
Previosly he worked as Clinician at Dodoma Regional Refferal Hospital (DRRH) under the USAID Afya Yangu Northern program, which is implemented by the Elizabeth Glaser Pediatric Foundation (EGPAF) and the Benjamin Mkapa Foundation (BMF).
HIV prevalence in Tanzania
The 2022–2023 Tanzania HIV Impact Survey found that HIV prevalence varies by region, ranging from 1.7% in Kigoma to 12.7% in Njombe.
___
Looks like Leronlimab's destination is the underserved regions that GF & ViiV(GSK) have targeted for decades.
Block, kill the resevoir & cure breastfeeding.
BG --- "a cure is on the way"
(2)
(0)
